0
Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

¾ÏȯÀÚ°¡ °æÇèÇÏ´Â Ç×¾ÏÈ­Çпä¹ý °ü·Ã ¸»ÃʽŰ溴Áõ

The Experience of Chemotherapy-induced Peripheral Neuropathy in People with Cancer

Á¾¾ç°£È£¿¬±¸ 2019³â 19±Ç 2È£ p.81 ~ 89
KMID : 1035120190190020081
¿Àº¹ÀÚ ( Oh Pok-Ja ) - »ïÀ°´ëÇб³ °£È£Çаú

ÃÖÀº¼÷ ( Choi Eun-Sook ) - ±¹¸³¾Ï¼¾ÅÍ
ÀÌÁø ( Lee Jin ) - »ïÀ°´ëÇб³ ´ëÇпø °£È£Çаú

Abstract

Purpose: The purpose of this study was to explore the experiences of adult cancer patients living with chemotherapy induced peripheral neuropathy (CIPN).

Methods: Data were collected from January 2018 to April 2018 through in-depth interviews with nine patients of colorectal and breast cancer. The main question was, ¡®What is your experience living with CIPN such as tingling and/or numbness?¡¯ . The data were analyzed using Colaizzi¡¯s phenomenological method.

Results: Three theme clusters and six themes emerged: (1) unusual body change; ¡®experience of unusual distressing symptoms¡¯ , ¡®daily activities and functioning affected¡¯ , (2) CIPN: a less important risk; ¡®CIPN: a distressing and have to endure¡¯ , ¡®lack of concern and therapeutic communication¡¯ , (3) struggle for distressing CIPN through trial and error; ¡®try all the remedies that can do¡¯ , ¡®getting used to distressing CIPN¡¯ .

Conclusion: These results showed that patients did not consider CIPN important until symptoms affected daily activities and QOL. They then tried self-management strategies to deal with CIPN through trial and error. A two-way exchange of information between patients and health professionals could help patients understand CIPN and deal with symptoms if they occur.
KeyWords
Ç×¾ÏÈ­Çпä¹ý, ¸»ÃʽŰ溴Áõ, ÁúÀû¿¬±¸
Chemotherapy, Peripheral neuropathy, Qualitative research
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed